Cellectis S.A. (LON:0WA2)
London · Delayed Price · Currency is GBP · Price in EUR 3.745
+0.250 (7.15%)
At close: Dec 19, 2025
Cellectis Market Cap
Cellectis has a market cap or net worth of 256.05 million as of December 22, 2025. Its market cap has increased by 142.91% in one year.
Market Cap
256.05M
Enterprise Value
283.33M
Revenue
61.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.75
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 66.49M to 256.05M, an increase of 285.08%. That is a compound annual growth rate of 7.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 256.05M | 163.99% |
| Dec 31, 2024 | 96.99M | -43.64% |
| Dec 29, 2023 | 172.10M | 114.24% |
| Dec 30, 2022 | 80.33M | -71.73% |
| Dec 31, 2021 | 284.18M | -69.41% |
| Dec 31, 2020 | 929.08M | 64.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| HSBC Holdings | 200.10B |
| Shell | 154.83B |
| Unilever | 108.28B |
| Rio Tinto Group | 99.46B |
| Rolls-Royce Holdings | 97.94B |
| British American Tobacco p.l.c. | 92.05B |
| GSK plc | 73.11B |